AIBP Protects Müller Glial Cells Against Oxidative Stress-Induced Mitochondrial Dysfunction and Reduces Retinal Neuroinflammation
Open Access
- 17 October 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (10) , 1252
Abstract
Glaucoma, an optic neuropathy with the loss of retinal ganglion cells (RGCs), is a leading cause of irreversible vision loss. Oxidative stress and mitochondrial dysfunction have a significant role in triggering glia-driven neuroinflammation and subsequent glaucomatous RGC degeneration in the context of glaucoma. It has previously been shown that apolipoprotein A-I binding protein (APOA1BP or AIBP) has an anti-inflammatory function. Moreover, Apoa1bp−/− mice are characterized by retinal neuroinflammation and RGC loss. In this study, we found that AIBP deficiency exacerbated the oxidative stress-induced disruption of mitochondrial dynamics and function in the retina, leading to a further decline in visual function. Mechanistically, AIBP deficiency-induced oxidative stress triggered a reduction in glycogen synthase kinase 3β and dynamin-related protein 1 phosphorylation, optic atrophy type 1 and mitofusin 1 and 2 expression, and oxidative phosphorylation, as well as the activation of mitogen-activated protein kinase (MAPK) in Müller glia dysfunction, leading to cell death and inflammatory responses. In vivo, the administration of recombinant AIBP (rAIBP) effectively protected the structural and functional integrity of retinal mitochondria under oxidative stress conditions and prevented vision loss. In vitro, incubation with rAIBP safeguarded the structural integrity and bioenergetic performance of mitochondria and concurrently suppressed MAPK activation, apoptotic cell death, and inflammatory response in Müller glia. These findings support the possibility that AIBP promotes RGC survival and restores visual function in glaucomatous mice by ameliorating glia-driven mitochondrial dysfunction and neuroinflammation.Keywords
Funding Information
- NIH (EY031697, EY034116, NS129684, AG081004, P30EY022589, HL136275, HL171505, AG081037)
- Research to Prevent Blindness (New York, NY) (EY031697, EY034116, NS129684, AG081004, P30EY022589, HL136275, HL171505, AG081037)
This publication has 45 references indexed in Scilit:
- Inflammation in Glaucoma: From the back to the front of the eye, and beyondProgress in Retinal and Eye Research, 2021
- Is 24(S)-hydroxycholesterol a potent modulator of cholesterol metabolism in Müller cells? An in vitro study about neuron to glia communication in the retinaExperimental Eye Research, 2019
- Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain StatesCell Reports, 2018
- Cholesterol metabolism and glaucoma: Modulation of Muller cell membrane organization by 24S-hydroxycholesterolChemistry and Physics of Lipids, 2017
- Association of Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile with the risk of primary open angle glaucomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradationAtherosclerosis, 2016
- Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's diseaseNeurobiology of Aging, 2015
- New functions of Müller cellsGlia, 2013
- Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequencesProgress in Retinal and Eye Research, 2006
- Cloning and Characterization of a Novel Apolipoprotein A-I Binding Protein, AI-BP, Secreted by Cells of the Kidney Proximal Tubules in Response to HDL or ApoA-IGenomics, 2002